Introduction
In Japan, cancer mortality is about 326,000 a year (1) .
Most of these cancer deaths are caused by distant metastasis, extensive diseases, or complications. Many cancer patients with advanced stages or distant metastasis at clinical presentation are eligible for treatments with non-curative intent or palliative care only.
As an effort to reduce the likelihood for distant metastasis in cancer patients, prompt access to a physician is generally recommended (2) SD=standard deviation.
All patients n=3893
T a b l e 1 . Ag e a n d Ge n d e r o f Al l P a t i e n t s wi t h Ca n c e r Based on one-way ANOVA with Scheffe multiple comparison tests to identify homogeneous groups at p<0.05.
T a b l e 2 . S y mp t o m-t o -v i s i t I n t e r v a l a mo n g P a t i e n t s wi t h Co mmo n Ca n c e r ( n > 3 0 )

Symptom-to-visit interval, days
SD=standard deviation.
The group 1 indicates the shortest interval, 2 for the middle interval, and 3 for the longest interval. i g u r e 1 . S y mp t o m-t o -p r e s e n t a t i o n i n t e r v a l b y c a n c e r t y p e a mo n g p a t i e n t s wi t h c o mmo n c a n c e r . Da r k b l u e , l i g h t b l u e a n d o r a n g e -c o (8, 9) ; menstrual, pelvic, or abdominal symptoms from ovarian cancer (10) ; jaun- 
l o r e d b a r s i n d i c a t e t h e c a n c e r g r o u p s wi t h t h e l o n g e s t , mi d d l e a n d s h o r t e s t s y mp t o m-t o -v i s i t i n t e r v a l s , r e s p e c t i v e l y .
Discussion
The results of our study, based on analysis of 3,893 cancer patients, indicate that the mean symptom-to-visit interval was 89 days (median, 30 days) for all cancer patients. We found three different groups of common cancer types based on the intervals: the group with the interval of days to weeks (brain, acute leukemia, ovary, hepatobiliary, pancreas cancers, and lymphoma); the group with the interval of months to years (skin, thyroid, head & neck, and breast cancer); and, the group with the interval of weeks to months (other types of cancer). Thus, patients with brain, acute leukemia, ovary, hepatobiliary, pancreas cancers, or lymphoma usually present at short intervals, while patients with skin, thyroid, head & neck, or breast cancer usually present at long intervals. For all cancer patients, symptom-to-visit intervals were not different by gender and age. This result is in line with a previous study, which revealed that no demographic or social factors were predictive of symptom recognition or delay in cancer patients (7). Mechanisms for the difference in symptom-to-visit intervals among patients with various cancer types may involve the characteristics of the site and growth rate of different cancer types. Because of the site of the diseases, patients with brain, ovary, or hepatobiliary, pancreas cancer, or lymphoma may rapidly develop symptoms: neurological symptoms or headache from brain cancer
T a b l e 3 . S y mp t o m-t o -v i s i t I n t e r v a l a n d Di s t a n t Me t a s t a s i s i n Co mmo n S o l i d Ca n c e r
T a b l e 4 . L o g i s t i c Re g r e e s i o n f o r Me t a s t a s i s i n Al l P a t i e n t s wi t h S o l i d Ca n c e r ( n = 3 3 1 0 )
